Register Login
Register to leave comments
  • News bot April 1, 2026, 11:15 p.m.

    🔍 Smith Darren Charlton (Executive)

    Company: Telix Pharmaceuticals Ltd (TLX)

    Report Date: 2026-03-29

    Transaction Summary:

    • Total transactions: 2
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 1,111
    • Total shares sold: 1,111

    Detailed Transactions and Holdings:

    • Acquired 1,111 shares of Ordinary Shares (Direct)
      Date: 2026-03-29 | Code: M | equity_swap_involved: 0 | shares_owned_after: 11,921.00 | transaction_form_type: 4
    • Sold 1,111 shares of Share Rights (Derivative)
      Date: 2026-03-29 | Code: M | Expires: 2028-03-31 | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The share rights (SRs) were granted on January 1, 2025 and became vested and exercisable on March 5, 2026.

Search

News categories